Voir la source de Austrianova is one firm

that does services that comprises high tech, life sciences and biotech. It is together with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science congregatedcombined organization that concentrate in the indusion of living cells or bacteria in little pills for protection which is also regarded as cell encapsulation technology, isolation, storage and transportation. We were first established in the year 2007 and was advanced in Singapore's greatest research biotech hub, Biopolis that has large-scale dream in providing encapsulation services like micro encapsulation. 

There is a rapid moving topic of liking in healthy maintenance and more exact, in the matter of neutraceuticals which is the teaching and use of probiotic bacteria. Therefore, probiotics encapsulation was formed. The cell-in-a-box technology was developed by Austranova with the target to defend, isolate, collect and transport living cells. This advanced creation can be used for many objectives and can be used to probiotics, cosmetics and agriculture environmental protection and watching as well as shaping the basis of a controlling study instrument. 

In healthcare, this knowledge supports run harmless implantation of cells or stem cells such as cell therapy, combining them isolated from the immune system and allowing long term production of therapeutic molecules in patients. In biotechnology, the cell-in-a-box creation shields cells in bioreactors and fermentors and at the same time, it simplifies purification of bioproducts formed from the cells and it shorten constructing price too.

A wide scale cGMP facility for the construction of biomedical grade encapsulated cell tools was actually effectively formed and right now, Austrianova is in the journey of setting up this experience in the whole of SE Asia. This means the use of cell-in-a-box was quite a achievement for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to allow lesser doses of chemotherapy to be used more efficaciously without the usual enervating side outcomes. The encapsulated cell are sited, using supraselective catheterisation, into blood vessels that flows to the tumor where they locally convert a chemotherapeutic product to its tumor toxic product. 

Come to our web for more information: <strong><b>[http://austrianova.com/ Cell Encapsulation]</b></strong>, <strong><b>[http://austrianova.com/ Micro Encapsulation]</b></strong>, <strong><b>[http://austrianova.com/ Encapsulation Services]</b></strong>.